European Pharmacopoeia Ph Eur Monograph Tablets 0478 Better [repack]

This change reduces risks for patients who split tablets, ensuring safety and efficacy when half-tablets are consumed. 2. Updated Dissolution and Disintegration Testing

The European Pharmacopoeia (Ph. Eur.) is a publication that sets out the quality standards for medicines in Europe. One of its key monographs is for tablets, which are a widely used dosage form for administering active pharmaceutical ingredients (APIs). The Ph. Eur. monograph for tablets, specifically monograph 0478, provides a comprehensive framework for ensuring the quality of tablets. In this article, we will explore the details of this monograph and what it means for the pharmaceutical industry. european pharmacopoeia ph eur monograph tablets 0478 better

This prevents "cherry picking" data. By requiring a profile, Ph. Eur. 0478 ensures the tablet behaves consistently over time, not just at the final time point. This is critical for modified-release and poorly soluble BCS Class II/IV drugs. This change reduces risks for patients who split